10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
The current price of TXG.MX is M$335.54 MXN — it has increased by +0% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange 10x Genomics stocks are traded under the ticker TXG.MX.
What is 10x Genomics market cap?▼
Today 10x Genomics has the market capitalization of 39.48B
When is the next 10x Genomics earnings date?▼
10x Genomics is going to release the next earnings report on May 06, 2026.
What were 10x Genomics earnings last quarter?▼
TXG.MX earnings for the last quarter are -2.24 MXN per share, whereas the estimation was -3.49 MXN resulting in a +35.89% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is 10x Genomics revenue for the last year?▼
10x Genomics revenue for the last year amounts to 23.72B MXN.
What is 10x Genomics net income for the last year?▼
TXG.MX net income for the last year is -1.64B MXN.
How many employees does 10x Genomics have?▼
As of April 11, 2026, the company has 1,239 employees.
In which sector is 10x Genomics located?▼
10x Genomics operates in the Healthcare sector.
When did 10x Genomics complete a stock split?▼
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?▼
10x Genomics is headquartered in Pleasanton, United States.